Pages with the fewest revisions

Showing below up to 50 results in range #1,801 to #1,850.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. 41. Invasive ductal carcinoma‏‎ (2 revisions)
  2. 21. Immunological tolerance‏‎ (2 revisions)
  3. 12. Chronic osteomyelitis (Garre, Brodie’s abscess)‏‎ (2 revisions)
  4. 62. General characteristics and types of chronic obstructive lung diseases‏‎ (2 revisions)
  5. B8. Clinical manifestations of gallstone disease. Laparoscopic cholecystectomy‏‎ (2 revisions)
  6. 65. Inflammatory skin diseases‏‎ (2 revisions)
  7. 3. Penetrating, chronic, ventricular ulcer (penetrating into pancreas)‏‎ (2 revisions)
  8. Bone marrow aspirate and biopsy‏‎ (2 revisions)
  9. Acute myocardial infarction‏‎ (2 revisions)
  10. 46. Melanocytic naevus and superficially spreading melanoma‏‎ (2 revisions)
  11. Prostate cancer‏‎ (2 revisions)
  12. 25. Wilms tumor‏‎ (2 revisions)
  13. Autoimmune hepatitis‏‎ (2 revisions)
  14. Small bowel neoplasm‏‎ (2 revisions)
  15. B15. Intrauterine growth restriction (IUGR)‏‎ (2 revisions)
  16. 51. Disturbances of amino acid metabolism‏‎ (2 revisions)
  17. 18. Diffuse large B-cell lymphoma (DLBCL)‏‎ (2 revisions)
  18. Supraventricular arrhythmias‏‎ (2 revisions)
  19. 37. Allergic reaction‏‎ (2 revisions)
  20. 18B. Types of disturbances of urinary bladder innervation‏‎ (2 revisions)
  21. 1. Introduction to immunology‏‎ (2 revisions)
  22. Melanoma‏‎ (2 revisions)
  23. De Quervain thyroiditis‏‎ (2 revisions)
  24. 19. Polycystic kidney (infantile sponge kidney)‏‎ (2 revisions)
  25. Endometrial cancer‏‎ (2 revisions)
  26. 4. Hemorrhagic infarct of the lung‏‎ (2 revisions)
  27. 11. Drug formulations. Prescription writing‏‎ (2 revisions)
  28. 40. General characteristics of benign and malignant tumours. Anaplasia. Rate of tumour cell growth. Local spread and metastasis of malignant neoplasms. Types of metastases.‏‎ (2 revisions)
  29. 20. Nosocomial infections. Sterilization, disinfection‏‎ (2 revisions)
  30. P2Y12 inhibitors‏‎ (2 revisions)
  31. Foreign body in the oesophagus‏‎ (2 revisions)
  32. A6. Asepsis and antisepsis, nosocomial infections‏‎ (2 revisions)
  33. A9. Cervical cancer; symptoms and diagnosis‏‎ (2 revisions)
  34. 13. Effector functions of antibodies‏‎ (2 revisions)
  35. Prealbumin‏‎ (2 revisions)
  36. Acute otitis media‏‎ (2 revisions)
  37. 24. Imaging of bone metastases. Radiologic and nuclear medicine techniques.‏‎ (2 revisions)
  38. 47. Tumours of adipose tissue and peripheral nerves, synovial sarcoma‏‎ (2 revisions)
  39. 25. Epidemiology and prevention of ulcer disease‏‎ (2 revisions)
  40. Impetigo‏‎ (2 revisions)
  41. Iron deficiency anaemia‏‎ (2 revisions)
  42. Chlamydia‏‎ (2 revisions)
  43. Knee ligament injuries‏‎ (2 revisions)
  44. 36. Endometrial adenocarcinoma (curettage)‏‎ (2 revisions)
  45. 18. Dilatative hypertrophy of the left ventricle of the heart‏‎ (2 revisions)
  46. Supraventricular premature beats‏‎ (2 revisions)
  47. A10. Endometrial cancer; symptoms and diagnosis‏‎ (2 revisions)
  48. Toe-brachial index‏‎ (2 revisions)
  49. B25. Tumor markers of malignant ovarian cancer. Diagnosis and treatment of borderline ovarian cancer.‏‎ (2 revisions)
  50. Non-HCC liver malignancies‏‎ (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)